INTANGIBLE ASSETS (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Sep. 30, 2020 |
Sep. 30, 2019 |
Sep. 30, 2020 |
Sep. 30, 2019 |
Dec. 31, 2019 |
Dec. 31, 2018 |
|
| Goodwill and Intangible Assets Disclosure [Abstract] | ||||||
| Patent costs | $ 155,507 | $ 155,507 | $ 127,593 | |||
| License costs | 241,909 | 241,909 | ||||
| Accumulated amortization of patent costs | 3,169 | 3,169 | 1,249 | |||
| Accumulated amortization of license costs | 11,232 | 11,232 | ||||
| Amortization expense | $ 640 | $ 313 | $ 13,152 | $ 742 | 1,055 | $ 194 |
| Patent costs | 127,593 | 53,482 | ||||
| Amortization of patent costs | $ 1,249 | $ 194 | ||||
| X | ||||||||||
- Definition Accumulated amortization of license costs. No definition available.
|
| X | ||||||||||
- Definition Accumulated amortization of patent costs. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The increase (decrease) during the reporting period in intangible assets (for example patents and licenses). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying amount (original costs adjusted for previously recognized amortization and impairment) as of the balance sheet date for the capitalized costs to acquire rights under a license arrangement (for example, to sell specified products in a specified territory) having an indefinite period of benefit. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after impairment of indefinite-lived intangible assets classified as other. Excludes financial assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|